These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37090535)

  • 1. Is neglect of self-clearance biassing TB vaccine impact estimates?
    Scarponi D; Clark RA; Weerasuriya C; Emery JC; Houben RM; White RG; McCreesh N
    medRxiv; 2023 May; ():. PubMed ID: 37090535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is neglect of self-clearance biasing TB vaccine impact estimates?
    Scarponi D; Clark RA; Weerasuriya CK; Emery J; Houben RMGJ; White R; McCreesh N
    BMJ Glob Health; 2023 Aug; 8(8):. PubMed ID: 37558271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01
    Clark RA; Weerasuriya CK; Portnoy A; Mukandavire C; Quaife M; Bakker R; Scarponi D; Harris RC; Rade K; Mattoo SK; Tumu D; Menzies NA; White RG
    BMC Med; 2023 Aug; 21(1):288. PubMed ID: 37542319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-clearance of
    Emery JC; Richards AS; Dale KD; McQuaid CF; White RG; Denholm JT; Houben RMGJ
    Proc Biol Sci; 2021 Jan; 288(1943):20201635. PubMed ID: 33467995
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential impact of tuberculosis vaccines in China, South Africa, and India.
    Harris RC; Sumner T; Knight GM; Zhang H; White RG
    Sci Transl Med; 2020 Oct; 12(564):. PubMed ID: 33028708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01
    Clark RA; Weerasuriya CK; Portnoy A; Mukandavire C; Quaife M; Bakker R; Scarponi D; Harris RC; Rade K; Mattoo SK; Tumu D; Menzies NA; White RG
    medRxiv; 2023 Jul; ():. PubMed ID: 36865172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study.
    Harris RC; Sumner T; Knight GM; Evans T; Cardenas V; Chen C; White RG
    Lancet Glob Health; 2019 Feb; 7(2):e209-e218. PubMed ID: 30630775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study.
    Clark RA; Portnoy A; Weerasuriya CK; Sumner T; Bakker R; Harris RC; Rade K; Mattoo SK; Tumu D; Menzies NA; White RG
    medRxiv; 2023 Sep; ():. PubMed ID: 37808744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China.
    Weerasuriya CK; Harris RC; McQuaid CF; Bozzani F; Ruan Y; Li R; Li T; Rade K; Rao R; Ginsberg AM; Gomez GB; White RG
    BMC Med; 2021 Feb; 19(1):60. PubMed ID: 33632218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects for a vaccine to prevent HIV-related tuberculosis.
    Nemes E; Scriba TJ; Hatherill M
    Curr Opin HIV AIDS; 2018 Nov; 13(6):522-527. PubMed ID: 30080682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling the health and economic impacts ofM72/AS01
    Sumner T; Clark RA; Mukandavire C; Portnoy A; Weerasuriya CK; Bakker R; Scarponi D; Hatherill M; Menzies NA; White RG
    Vaccine; 2024 Feb; 42(6):1311-1318. PubMed ID: 38307747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis.
    Bénard É; Drolet M; Laprise JF; Jit M; Prem K; Boily MC; Brisson M
    Lancet Glob Health; 2023 Jan; 11(1):e48-e58. PubMed ID: 36521952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New tuberculosis vaccines: advances in clinical development and modelling.
    Weerasuriya CK; Clark RA; White RG; Harris RC
    J Intern Med; 2020 Dec; 288(6):661-681. PubMed ID: 33128834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study.
    Clark RA; Mukandavire C; Portnoy A; Weerasuriya CK; Deol A; Scarponi D; Iskauskas A; Bakker R; Quaife M; Malhotra S; Gebreselassie N; Zignol M; Hutubessy RCW; Giersing B; Jit M; Harris RC; Menzies NA; White RG
    Lancet Glob Health; 2023 Apr; 11(4):e546-e555. PubMed ID: 36925175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
    Fu H; Lin HH; Hallett TB; Arinaminpathy N
    Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.
    Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group
    Vaccine; 2015 Jun; 33(26):3047-55. PubMed ID: 25882170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study.
    Portnoy A; Arcand JL; Clark RA; Weerasuriya CK; Mukandavire C; Bakker R; Patouillard E; Gebreselassie N; Zignol M; Jit M; White RG; Menzies NA
    PLoS Med; 2023 Jul; 20(7):e1004252. PubMed ID: 37432972
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.